Back to top
more

Organon & Co. (OGN)

(Delayed Data from NYSE)

$20.88 USD

20.88
1,723,323

+0.96 (4.82%)

Updated Jul 11, 2024 04:00 PM ET

After-Market: $20.89 +0.01 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note

by Zacks Equity Research

In the most recent trading session, Organon (OGN) closed at $19.93, indicating a -1.04% shift from the previous trading day.

Do Options Traders Know Something About Organon (OGN) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Organon (OGN) stock based on the movements in the options market lately.

Organon (OGN) Stock Sinks As Market Gains: Here's Why

by Zacks Equity Research

In the most recent trading session, Organon (OGN) closed at $20.63, indicating a -0.77% shift from the previous trading day.

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Encompass Health (EHC) Gains 30% in a Year: More Room to Run?

by Zacks Equity Research

Encompass Health (EHC) is well-poised for growth on the back of sustained top-line growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.

Is Ocugen (OCGN) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Ocugen (OCGN) and Organon (OGN) have performed compared to their sector so far this year.

Humana's (HUM) CenterWell Expands in Louisiana With New Centers

by Zacks Equity Research

Humana's (HUM) CenterWell unit is likely to benefit from the opening of four new centers in the Baton Rouge and New Orleans areas in Louisiana, thus enhancing healthcare access for local seniors.

Organon (OGN) Advances While Market Declines: Some Information for Investors

by Zacks Equity Research

Organon (OGN) closed the most recent trading day at $20.45, moving +0.49% from the previous trading session.

Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DES

Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock

by Zacks Equity Research

HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and solid cash-generating abilities.

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Ensign Group (ENSG) Buys Facilities in Arizona & Colorado

by Zacks Equity Research

Ensign Group (ENSG) expands its footprint by acquiring skilled nursing facilities in Arizona and Colorado, enhancing its healthcare services and real estate portfolio.

Organon (OGN) Just Overtook the 20-Day Moving Average

by Zacks Equity Research

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Tenet Healthcare (THC) Gains 89% in a Year: More Room to Run?

by Zacks Equity Research

Tenet Healthcare (THC) is well-poised to gain from improved volumes, expansion of specialty services, streamlining operations and operational efficiency.

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

by Zacks Equity Research

Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Centene (CNC) Expands CHS Network, Shifts AcariaHealth Facility

by Zacks Equity Research

Centene's (CNC) subsidiaries, CHS and AcariaHealth, enhance patient outcomes with CHS' CIPA entering Virginia and AcariaHealth's pharmacy facility relocating to Chesterfield, thereby expanding CNC's capabilities.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for DES

Zacks.com featured highlights include Vital, Sprouts Farmers, Royal Caribbean, Agnico and Organon

by Zacks Equity Research

Vital, Sprouts Farmers, Royal Caribbean, Agnico and Organon have been highlighted in this Screen of The Week article.

Nilanjan Choudhury headshot

5 Relative Price Strength Stocks With Strong Return Potential

by Nilanjan Choudhury

VITL, SFM, RCL, AEM and OGN are five stocks with explosive relative price strength.

Why You Should Add Encompass Health (EHC) to Your Portfolio Now

by Zacks Equity Research

Encompass Health (EHC) remains well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, joint ventures and solid cash reserves.

Nexstar Media and ASGN have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Nexstar Media and ASGN have been highlighted as Zacks Bull and Bear of the Day.

Tirthankar Chakraborty headshot

Is Stagflation Round the Corner? 3 Ultra-Safe Picks

by Tirthankar Chakraborty

Since it's becoming difficult to downplay the idea of stagflation, investors should place their bets on ultra-safe stocks such as Western Union (WU), Frontline (FRO) and Organon (OGN).

Surging Earnings Estimates Signal Upside for Organon (OGN) Stock

by Zacks Equity Research

Organon (OGN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Best Value Stocks to Buy for May 13th

by Zacks Equity Research

OGN, ODP and ASC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 13, 2024.